Matthew Fell

Matthew Fell is an experienced Ph.D. level biologist with over ten years of drug discovery experience in large pharmaceutical companies.

He specializes in the field of neuroscience, particularly in psychiatric and neurodegenerative disorders, and has been involved in leading therapeutic programs focused on Alzheimer's and Parkinson's diseases.

In his role as Lab Head and Program Team Leader, Matthew has demonstrated expertise in designing and executing pre-clinical studies to understand the mechanism of novel therapeutic agents, biomarker discovery/development, and identifying/evaluating new targets.

Known for his exceptional communication skills, Matthew is proficient in presenting scientific information to diverse audiences and has a proven track record of establishing successful collaborations with internal and external partners, including academic institutions and CRO organizations.

Matthew Fell currently holds the position of Director of Neuroscience/Neuroimmunology at Merck, having previously served in various roles within the Neuroscience division at Merck and as a Post-Doctoral Research Fellow at Eli Lilly and Company.